authors
- Ambarish Pandey, MD, MSCS
- Basu, Sudipta
- Kohandel, Mohammad
- Sengupta, Shiladitya
- Kulkarni, Ashish
- Roy, Bhaskar
- Goldman, Aaron
- Sarangi, Sasmit
- Sengupta, Poulomi
- Phipps, Colin
- Kopparam, Jawahar
- Oh, Michael
Sequential application of a cytotoxic nanoparticle and a PI3K inhibitor enhances antitumor efficacy.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2013
published in
- Cancer research Journal
has subject area
- Animals
- Antineoplastic Agents
- Breast Neoplasms
- Cell Line, Tumor
- Cell Survival
- Cisplatin
- ErbB Receptors
- Female
- Humans
- Mice
- Models, Biological
- Nanoparticles
- Phosphatidylinositol 3-Kinases
- Phosphoinositide-3 Kinase Inhibitors
- Protein Kinase Inhibitors
- Proto-Oncogene Proteins c-akt
- Reproducibility of Results
- Signal Transduction